OpenFilings

Arcutis Biotherapeutics, Inc.

Form10-K/A

Report Period2022-12-31

Date Filed2023-09-15

Time Filed16:07:12

Document Analysis

Natural Language Processing

Recognized Type Unidentified

Defined Term Format

Exhibits

10-K/A
RULE 13A-14(A) CERTIFICATION CEO
RULE 13A-14(A) CERTIFICATION CFO
Filing on SEC Edgar